Prof. Dr. Dimitrios Farmakis graduated from the Medical School of the National and Kapodistrian University of Athens and received his Doctoral Degree in hemoglobinopathy-associated heart disease from the same university in 2003. He received his board certification in 2008. He was further trained in Cardio-Oncology at Bern University Hospital "Inselspital", Bern, Switzerland, in Heart Failure at Zurich University Medical School, Zurich, Switzerland, and in Clinical Trials at Harvard Medical School, Boston, USA. He worked at the National and Kapodistrian University of Athens Medical School between 2008 and 2017 (Heart Failure Unit, Athens University Hospital "Attikon"). In 2017, he was an Assistant Professor of Pathophysiology at the European University of Cyprus Medical School and was promoted to Associate Professor of Physiology in 2018. He served as a member of the European Society of Cardiology (ESC) Guidelines Committee for Cardio-Oncology in 2016. He is the most recent President of the Working Group for Cardiomyopathies and Basic Research of the Hellenic Society of Cardiology, a Fellow of the European Society of Cardiology (ESC), a member of the Heart Failure Association (HFA) of the ESC, a member of the Cardio-Oncology Committee of the HFA, and an ex officio member of the Board of the ESC Cardio-Oncology Council. Finally, he has received awards from Greek and international organizations and scientific bodies.
Prof. Dr. Dimitrios Farmakis graduated from the Medical School of the National and Kapodistrian University of Athens and received his Doctoral Degree in hemoglobinopathy-associated heart disease from the same university in 2003. He received his board certification in 2008. He was further trained in Cardio-Oncology at Bern University Hospital "Inselspital", Bern, Switzerland, in Heart Failure at Zurich University Medical School, Zurich, Switzerland, and in Clinical Trials at Harvard Medical School, Boston, USA. He worked at the National and Kapodistrian University of Athens Medical School between 2008 and 2017 (Heart Failure Unit, Athens University Hospital "Attikon"). In 2017, he was an Assistant Professor of Pathophysiology at the European University of Cyprus Medical School and was promoted to Associate Professor of Physiology in 2018. He served as a member of the European Society of Cardiology (ESC) Guidelines Committee for Cardio-Oncology in 2016. He is the most recent President of the Working Group for Cardiomyopathies and Basic Research of the Hellenic Society of Cardiology, a Fellow of the European Society of Cardiology (ESC), a member of the Heart Failure Association (HFA) of the ESC, a member of the Cardio-Oncology Committee of the HFA, and an ex officio member of the Board of the ESC Cardio-Oncology Council. Finally, he has received awards from Greek and international organizations and scientific bodies.